Pharmaceutical Pricing and Reimbursement Information (PPRI)
|
|
- Leona McDaniel
- 5 years ago
- Views:
Transcription
1 Pharmaceutical Pricing and (PPRI) GÖG/ÖBIG Sabine Vogler HSWP Meeting, 12 June 2007
2 Pharmaceutical Pricing and - PPRI Rationale Objectives Project organisation Work packages and deliverables Preliminary results & Evaluation
3 Rationale 27 different pharmaceutical pricing and reimbursement systems in the enlarged EU Need for knowledge and analysis of PPRI and exchange of information and experience between policy-makers Previous and ongoing work: Post G10 process WHO ÖBIG studies EURO-MED-STAT EURO DURG Pharmaceutical Forum (Pricing Relative Effectiveness Patient Information)
4 PPRI - Timetable Project proposal submission: May 2004 Project start: Spring 2005 PPRI Conference: 29 June 2007 Project end: Autumn 2007
5 PPRI Objectives Strengthening the networking of the relevant national authorities and institutions in the field of pharmaceuticals in the Member States Assessing the needs of EU and national administration and policymakers with regard to knowledge and information transfer on PPRI Country reports on pharmaceutical pricing and reimbursement ( Pharma Profiles ) Developing indicators for the comparative analysis Dissemination of the project results
6 PPRI - Project organisation Commissioners: European Commission - DG Sanco; Austrian Federal Ministry of Health, Family and Youth Project leaders: GÖG/ÖBIG, WHO Europe Participants at Member State level: competent authorities, Medicines Agencies, Third Party Payers, research institutes at European / international level: EMEA, OECD, DG Enterprise, World Bank Cooperation with other projects and initiatives: EUROMEDSTAT, SOGETI, EASP, Pharmaceutical Forum, MEDEV A network of 46 participating institutions EU Member States + AL, CA, NO, TR
7 PPRI Work packages WP 1: Coordination GÖG/ÖBIG, throughout the whole project WP 2: Dissemination GÖG/ÖBIG, WHO and all PPRI participants - throughout the whole project WP 3: Assessment WHO, presentation of results - April 2006 WP4: Survey WHO, presentation of first Pharma Profiles October 2006 WP 5: Development of comparable indicators GÖG/ÖBIG, presentation - March 2007 WP 6: Comparative Analysis GÖG/ÖBIG, draft comparative analysis - March 2007
8 PPRI WP 1 Coordination Keeping the network active Ensuring information flow (5 Coordination Meetings, Intranet) Active commitment of participants PPRI WP 2 Dissemination PPRI website: Publications Presentations PPRI Conference, Vienna, 29 June 2007
9 PPRI WP 3 Assessment Survey: 101 institutions on national level and 14 on European level Deliverable: Needs Assessment Report Results - Background information on pharmaceutical pricing and reimbursement - Pharmaceutical pricing, reimbursement, cost-containment, evaluation PPRI WP 5 Indicators Analysis of all relevant indicators in the pharmaceutical field Development and approval of a core set of PPRI indicators Deliverable: 21 qualitative and quantitative indicators
10 PPRI WP 4 Survey/1 Deliverable: Pharma Profiles = country profiles on the pharmaceutical pricing and reimbursement Basis: Detailed outline ( Pharma Profile Template ) Overview of the chapters: 1 Background 4 Reimbursement 2 Pharmaceutical System 5 Rational use of pharmaceuticals 3 Pricing 6 Current challenges Common terminology: PPRI glossary (
11 Why do we need a common language? Reference Price System International Referencing External Referencing Margin Mark up ATC 4 Level Cross-Country Price Comparison
12 PPRI WP 4 Survey/2 Authors: PPRI participants Editorial Team Currently 21 Pharma Profiles Pharma Profiles will be available on the PPRI website for downloading / on CD Rom
13 PPRI WP 6 Comparative Analysis/1 Comparable analysis of the country specific results taken from the Pharma Profiles Basis: Core list of PPRI indicators Numerous overview tables and figures Results will be presented at PPRI Conference Part of PPRI Report
14 PPRI WP 6 Comparative Analysis/2 Preliminary results - Pricing Price setting for the reimbursable segment Comparison with prices in other countries Regulations of mark-ups Specific VAT rates Preliminary results - Reimbursement Positive lists Percentage co-payment of reimbursable pharmaceuticals Reference Price System (different methods) Co-payment as a cost-containment measure
15 PPRI Preliminary evaluation/1 Common understanding Common terminology / glossary Indicators for pharmaceuticals Data availability and comparability Gap on hospital market Need for regular updates
16 PPRI Preliminary evaluation/ Accessibility and affordability in the context of cost-containment More exchange of information Keep the network alive
17 PPRI Conference 29 June 2007 Akademie der Wissenschaften Registration: Contact:
18 This paper was produced for a meeting organized by Health & Consumer Protection DG and represents the views of its author on the subject. These views have not been adopted or in any way approved by the Commission and should not be relied upon as a statement of the Commission's or Health & Consumer Protection DG's views. The European Commission does not guarantee the accuracy of the data included in this paper, nor does it accept responsibility for any use made thereof.
COMMISSIONED BY EUROPEAN COMMISSION, DIRECTORATE-GENERAL HEALTH AND CONSUMER PROTECTION AND AUSTRIAN FEDERAL MINISTRY OF HEALTH, FAMILY AND YOUTH
GÖG/ÖBIG REPORT COMMISSIONED BY EUROPEAN COMMISSION, DIRECTORATE-GENERAL HEALTH AND CONSUMER PROTECTION AND AUSTRIAN FEDERAL MINISTRY OF HEALTH, FAMILY AND YOUTH GÖG/ÖBIG PPRI REPORT Author: Sabine Vogler
More informationPharmaceutical Pricing and Reimbursement Information (PPRI) New PPRI analysis including Spain
Pharmaceuticals Policy and Law 11 (2009) 213 234 213 DOI 10.3233/PPL-2009-0222 IOS Press Pharmaceutical Pricing and Reimbursement Information (PPRI) New PPRI analysis including Spain Sabine Vogler a,,
More information5th Meeting of the Working Group on Relative Effectiveness
5th Meeting of the Working Group on Relative Effectiveness Brussels, 2 October 2007, 10.30 16.30 hrs Room 1 D, 1st floor, Centre de Conference Albert Borschette Note of the Meeting Chairs: Morning session:
More informationPharmaceutical policies in response to the financial i crisis i - results from policy monitoring in the EU
Pharmaceutical policies in response to the financial i crisis i - results from policy monitoring in the EU Sabine Vogler Gesundheit Österreich/Austrian Health Institute Head of Pharma Team PPRI/PHIS Project
More informationKick off meeting objectives
Kick off meeting objectives 1. Understand the overall aims and strategic objectives of Euro Histio net 2. Appreciate how you will contribute to the project s success 3. Develop a greater understanding
More informationSabine Vogler, PhD Gesundheit Österreich GmbH Vienna, Austria. Differential Pricing of Medicines in Europe
Speaker Sabine Vogler, PhD Gesundheit Österreich GmbH Vienna, Austria Differential Pricing of Medicines in Europe Sabine Vogler WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies
More informationPharmaceutical Pricing and Reimbursement Information. SWEDEN June 2007
ÖBIG Pharmaceutical Pricing and Reimbursement Information SWEDEN June 2007 Commissioned by European Commission, Health and Consumer Protection Directorate-General and Austrian Ministry of Health, Family
More informatione-application Form User Guide ENI CBC Med Programme - Managing Authority Regione Autonoma della Sardegna
e-application Form User Guide ENI CBC Med Programme - Managing Authority Regione Autonoma della Sardegna eaf - User Guide intro This guide takes you through the electronic application form (eaf) to submit
More informationCLARIN-PLUS WP1 - Management. Hetty Winkel, Franciska de Jong Utrecht, 9 September 2015
CLARIN-PLUS WP1 - Management Hetty Winkel, Franciska de Jong Utrecht, 9 September 2015 WP1 Objectives To take care of the financial, administrative and legal execution of the project in accordance with
More informationPharmaceutical Pricing and Reimbursement Information. BULGARIA June 2007
ÖBIG Pharmaceutical Pricing and Reimbursement Information BULGARIA June 2007 Commissioned by European Commission, Health and Consumer Protection Directorate-General and Austrian Ministry of Health, Family
More informationAdministrative, Financial and Operational Aspects of Project Management
Administrative, Financial and Operational Aspects of Project Management European Commission Directorate General Environmental Technologies Unit Presentation 1. General overview of Grant Agreement 2. Duties
More informationWhy? Disclaimer: Information not legally binding
LUMP SUM PILOT Why? Why? Simplification: No financial reporting, no time sheets, no financial audit. Payment exclusively based on completion of activity. Pilot scheme to evaluate results view to FP9 Start
More informationLawyer Chief Expert at the Ministry of Health
by Jakub Adamski Vienna, 30/09/2011 Lawyer Chief Expert at the Ministry of Health participation in European Commission and Council working groups member of the EUCERD coordination of works of the Rare
More informationShort PPRI Pharma Profile. Turkey 2017
Short PPRI Pharma Profile 2017 Short PPRI Pharma Profile Update: January 2017 PPRI Representatives Prof. Dr. Mehtap Tatar Authors Prof. Dr. Mehtap Tatar Disclaimer The data provided in this document by
More informationEuratom Joint Programme in Radioactive Waste Management - from Reflections (2015) to Requirements (2016)
Euratom Treaty, signature 1957 Euratom Joint Programme in Radioactive Waste Management - from Reflections (2015) to Requirements (2016) IGD-TP Exchange Forum #7, Cordoba, October 2016 DG Research and Innovation
More informationGouvernance et Emergence de la Recherche en Sciences Humaines au Cambodge GEReSH-CAM
1 Gouvernance et Emergence de la Recherche en Sciences Humaines au Cambodge GEReSH-CAM Quality Assurance Plan www.geresh-cam.eu 2 Réferentiel projet Dear Partners, This Quality Assurance Plan summarises
More informationChallenges in Reimbursing Orphan Medicinal Products. Evaluating Benefit, Determining a Fair Price and Optimizing Access
Challenges in Reimbursing Orphan Medicinal Products Evaluating Benefit, Determining a Fair Price and Optimizing Access Acknowledgements This presentation reflects the work of colleagues at the Department
More information2011 SURVEY ON MONITORING THE PARIS DECLARATION
TASK TEAM ON MONITORING THE PARIS DECLARATION 2011 SURVEY ON MONITORING THE PARIS DECLARATION Revised Survey Materials Initial Annotated Draft 3 May 2010 FOR COMMENT This initial text with annotations
More informationFP6 Contract and Financial Reporting. The Basics for EC Consortia. Linda Polik Research Services
FP6 Contract and Financial Reporting The Basics for EC Consortia Linda Polik Research Services linda.polik@admin.ox.ac.uk Overview of Presentation 1) Contractual Issues 2) Financial Issues 3) Reporting
More informationReform des Zulassungssystems von Arzneimitteln in der EU - Position der EU Kommission
Reform des Zulassungssystems von Arzneimitteln in der EU - Position der EU Kommission DGRA Jahreskongreß 21. - 22. Mai 2003 Birka Lehmann EUROPEAN COMMISSION Enterprise Directorate-General Pharmaceuticals
More informationFirst Balkan Forum on: Health Care Reform
First Balkan Forum on: Health Care Reform ALBANIA: AN OVERVIEW of THE HEALTH SYSTEM & HEALTH INSURANCE SCHEME Ms. Elvana Hana General Director Albanian Health Insurance Institute November 2007 1 Albania
More informationAIFP CODE ON DISCLOSURE OF TRANSFERS OF VALUE FROM PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTHCARE ORGANISATIONS
AIFP CODE ON DISCLOSURE OF TRANSFERS OF VALUE FROM PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTHCARE ORGANISATIONS Approved by the AIFP General Meeting on 21 November 2013, last revision
More informationProject Solvency II Rolf Stölting
Project Solvency II Rolf Stölting Québec, June 2008 1 Overview of initiatives / working groups Parliament Council Steering Group Solvency II CEA ECON Committee GDV ABI FFSA EU Commission CRO Forum AMICE
More informationFinance, Performance and Strategic Planning Committee Terms of Reference
Finance, Performance and Strategic Planning Committee Terms of Reference Document Control: Document Document Owner: Board of Directors JPUH Finance, Performance and Strategic Planning Electronic File Name:
More informationFramework Programmes
GZ: RL/10-ZGI/2017 Framework Programmes Co-financing of Austrian Civil Society Organisations (CSOs) Funding Guideline the operational unit of the Austrian Development Cooperation Zelinkagasse 2, 1010 Vienna,
More informationWP1 Administration, coordination and reporting
ECGFA NET II Work Plan WP1 Administration, coordination and reporting Content 1. Work package objectives... 1 2. Project Management of the ECGFA NET II Project... 1 2.1 Organization and Decision Making
More informationACCESS TO ESSENTIAL MEDICINES IN PORTUGAL
ÖBIG FORSCHUNGS- UND PLANUNGSGESELLSCHAFT mbh ACCESS TO ESSENTIAL MEDICINES IN PORTUGAL COMMISSIONED BY HEALTH ACTION INTERNATIONAL EUROPE ACCESS TO ESSENTIAL MEDCINES IN PORTUGAL July 2009 ÖBIG Forschungs-
More informationP Periodic project report Please remove this front page when using the template
P Periodic project report Please remove this front page when using the template IMI1 programme Template for periodic project report Recommendations for project coordinators When preparing a periodic report,
More informationTerms of Reference for an Individual National Consultant to conduct the testing of the TrackFin Methodology in Uganda.
Terms of Reference for an Individual National Consultant to conduct the testing of the TrackFin Methodology in Uganda 21 July, 2017 Introduction: The Ministry of Water and Environment (MWE) is implementing
More informationLITHUANIA October 2007
ÖBIG Pharmaceutical Pricing and Reimbursement Information LITHUANIA October 2007 Commissioned by European Commission, Health and Consumer Protection Directorate-General and Austrian Ministry of Health,
More informationJORDAN. Terms of Reference
JORDAN Terms of Reference Jordan: Strengthening municipal financial management systems to sustain service delivery in municipalities affected by the refugee crisis Assessment of Municipal Public Financial
More informationGuidelines for the AF DSP call for proposals
Guidelines for the AF DSP call for proposals A stream of cooperation edited by the Managing Authority/Joint Secretariat Budapest, Hungary, 2018 Programme co-funded by the European Union Table of content
More informationPharmaceutical Pricing and Reimbursement Information. SLOVAKIA June 2007
ÖBIG Pharmaceutical Pricing and Reimbursement Information SLOVAKIA June 2007 Commissioned by European Commission, Health and Consumer Protection Directorate-General and Austrian Ministry of Health, Family
More informationShort term indicators
Short term indicators Seminar on developing the capacity to produce economic statistics, including national accounts in accordance with the 2008 SNA, in the Asian and Pacific region 10-13 October 2011,
More informationGENERA guidelines on reporting. Kick-off Meeting Brussels. Paula Mota Alves
GENERA guidelines on reporting Kick-off Meeting 17.09.2015 Brussels Paula Mota Alves Unit B5 Spreading Excellence, Widening Participation, Science with and for Society Outline of presentation o Horizon
More informationShort PPRI Pharma Profile. Austria 2017
Short PPRI Pharma Profile 2017 Short PPRI Pharma Profile January 2018 PPRI Representatives Gesundheit Österreich GmbH (GÖG): Sabine Vogler, Nina Zimmermann, Margit Gombocz Main Association of n Social
More informationGuidelines and how to prepare and carry out a SLIC Campaign
EUROPEAN COMMISSION Employment, Social Affairs and Inclusion DG Employment and Social Legislation, Social Dialogue Health, Safety and Hygiene at Work Adopted at the 66th SLIC Plenary Athens, Greece 27
More informationGUIDELINE ON THE PROCESSING OF RENEWALS IN THE CENTRALISED PROCEDURE
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 19.12.2005 ENTR/F2/KK D(2005) Revision 2005 NOTICE TO APPLICANTS VETERINARY MEDICINAL PRODUCTS GUIDELINE
More informationCost-containment policies in public pharmaceutical spending in the EU
MPRA Munich Personal RePEc Archive Cost-containment policies in public pharmaceutical spending in the EU Giuseppe Carone and Christoph Schwierz and Ana Xavier European Commission - General Directorate
More informationPharmaceutical Pricing and Reimbursement A Global Perspective. Andreas Seiter The World Bank PPRI Conference, September 2011
Pharmaceutical Pricing and Reimbursement A Global Perspective Andreas Seiter The World Bank PPRI Conference, September 2011 The World Bank and its Clients Financing (IDA, subsidized) Low-Income Countries
More informationAn international call for research. Taking Stock of Public Private Partnerships and Private Finance Initiatives Around the World
An international call for research Taking Stock of Public Private Partnerships and Private Finance Initiatives Around the World 2 An international call for research ACCA wishes to commission research with
More informationProject Administration
Co-funded by the European Union Project Administration Maria Grazia Bonanomi, UCSC Diverse Kick-off meeting - Milan, 22-24 January 2014 Outline: - Context - Key features - Final Reporting Package - Eligible
More informationOngoing activities in the field of employment and social affairs - update. 05 March 2013
Ongoing activities in the field of employment and social affairs - update 05 March 2013 European Council 13-14 December 2012 Paragraph 12b of the conclusions Roadmap for the completion of the Economic
More informationMaking the case for Horizon Scanning
Making the case for Horizon Scanning Facing the challenges: Equity, Sustainability and Access Aldo Golja, Beneluxa Coordinator Ministry of Health, The Netherlands 1 Introduction Samuel Becket bridge, Dublin
More informationCo-financing mechanisms Budget cap Pay back Risk-sharing instruments Reimbursement tax
LINKING TODAY S DECISIONS WITH TOMORROW S POSSIBILITIES: HTA: LINKING TODAY S DECISIONS WITH TOMORROW S POSSIBILITIES: A PERSPECTIVE FROM POLAND, HUNGARY, GREECE AND SERBIA A PERSPECTIVE FROM POLAND Speakers:
More informationProcedure: Policy governance
Procedure: Policy governance Purpose The purpose of this procedure is to provide for the operationalisation of the Policy Governance Policy. Procedure Categories 1. The appropriate category for a policy
More informationGeographic & Thematic Programming of EU aid
Geographic & Thematic Programming of EU aid EU Budget 2014-2020 CONCORD presentation at Policy Forum for Development 18th June 2013 Alexandra Makaroff Chair of the Funding for Development & Relief (FDR)
More informationTERMS OF REFERENCE FOR INDIVIDUAL CONTRACTORS
TERMS OF REFERENCE FOR INDIVIDUAL CONTRACTORS ASSIGNMENT TITLE: International Planning/Budgeting Expert Discussion Paper - Integration of the SDGs into Myanmar s Planning and Budgeting Frameworks DURATION:
More informationValue for money and valued innovation: A trade-off or mutually compatible goals?
Value for money and valued innovation: A trade-off or mutually compatible goals? Elizabeth Docteur Deputy Head, OECD Health Division OECD High-Level Symposium on Pharmaceutical Pricing Policy 27 October
More informationThe Pharmaceutical Market: Did we Learned the Crisis Lessons? Petru Crăciun ZF Pharma Bucharest 2014, September 29th
The Pharmaceutical Market: Did we Learned the Crisis Lessons? Petru Crăciun ZF Pharma Bucharest 2014, September 29th The Pharmaceutical Market Pharma Market MAT(2008 - M6) MAT(2014 - M6) +/- % Total Units
More informationAustrian Partnership Practice:
Austrian Partnership Practice: The Austrian TEPs, its network and Co-ordination Unit (TEP: Territorial Employment Pacts) Zagreb, March 2008 The Austrian TEP rationale Labour market challenges exist, which
More informationLEO Pharma Global Methodological Note to EFPIA HCP/HCO Disclosure Requirements
LEO Pharma Global Methodological Note to EFPIA HCP/HCO Disclosure Requirements ALL LEO TRADEMARKS MENTIONED BELONG TO THE LEO GROUP 2/14 Contents 1 Introduction... 3 2 Purpose... 3 3 Terminology and Definitions...
More informationPractical guidance on the extension of Commission Decision Annexes in the new Accession Country languages
The European Agency for the Evaluation of Medicinal Products London, 7 May 2004 Doc. Ref: EMEA/H/29754/03/Rev 1 Practical guidance on the extension of Commission Decision Annexes in the new Accession Country
More informationARPIM HCP/HCO DISCLOSURE CODE
ARPIM HCP/HCO DISCLOSURE CODE ARPIM CODE ON THE DISCLOSURE OF SPONSORSHIPS AND OTHER TRANSFERS OF VALUE FROM PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO)
More informationProject Implementation Seminar
Project Implementation Seminar Financial Flows George Papapostolou Financial Officer JS Financial Flows Project implementation lifecycle Cash Flow Pre-Financing Amortization Cash Flow Pre-Financing Estimations
More informationStrategic Partnerships
GZ: RL/6-OE/2017 Strategic Partnerships with Austrian Civil Society Organisations (CSOs) Funding Guideline the operational unit of the Austrian Development Cooperation Zelinkagasse 2, 1010 Vienna, phone:
More informationAny healthcare professional and healthcare organisation whose primary practice, principal professional address or place of incorporation
METHODOLOGICAL NOTE on the EFPIA disclosure of transfers of value to healthcare professionals and organisations Country: Finland Last Update: 25.04.2018 Version: 02; this document replaces previous drafts
More informationModerator: J van Loon,MSc Mapi. Advisor to the President, Head of International Affairs, HAS France
Comparing the challenges of comparative effectiveness Research in France, Italy and the Netherlands Current Situation and Perspectives Issue Panelists: F. Meyer, MD Advisor to President, France E. Xoxi,
More informationArkansas Health Insurance Marketplace Key Decisions Inventory. April 9, 2014
I. Introduction and Methodology Introduction Over the next six weeks, Public Consulting Group (PCG) will assemble an inventory of key decisions that the Board and the Executive Director may use to establish
More informationINEA. Innovation and Networks Executive Agency. Making implementation happen
INEA Innovation and Networks Executive Agency Making implementation happen Michal KLIMA H2020 Transport Research, INEA Transport Research Arena 2016 Warsaw, 21 April 2016 Agenda Presentation of INEA H2020
More informationDrug Reimbursement - Croatia. Roganovic Jelena
Drug Reimbursement - Croatia Roganovic Jelena Population: 4,292,095 (July 2017) Area: 56,594 km 2 Density: 75.8/km 2 21 counties http://www.lokalniizbori.com/wp-content/uploads/2013/04/hrvatska-%c5%beupanije.jpg;
More information2 nd INDEPENDENT EXTERNAL EVALUATION of the EUROPEAN UNION AGENCY FOR FUNDAMENTAL RIGHTS (FRA)
2 nd INDEPENDENT EXTERNAL EVALUATION of the EUROPEAN UNION AGENCY FOR FUNDAMENTAL RIGHTS (FRA) TECHNICAL SPECIFICATIONS 15 July 2016 1 1) Title of the contract The title of the contract is 2nd External
More informationNovartis Methodological Note
Novartis Methodological Note on Disclosure of Payments and other Transfers of Values to Health Care Professionals and Health Care Organizations following the EFPIA Code on Disclosure of Transfers of Value
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
EN EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, COM(2008) 400/2 COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE
More informationPayment Policy: Leveling of Emergency Room Services Reference Number: TX.PP.053 Product Types: ALL
Payment Policy: Leveling of Emergency Room Services Reference Number: TX.PP.053 Product Types: ALL Effective Date: 10/01/2017 Last Review Date: See Important Reminder at the end of this policy for important
More informationWorking Group on Public Health statistics
Working Group on Public Health statistics Agenda item 8.2 Main projects and data collection Health Expenditure Statistics (SHA) 26-27 October 2009 EUROSTAT: Working Group Public Health Meeting SHA Joint
More informationProject Start and End Date 01/ /2019 Kommentar [aa1]: data on website flyer says: > Please note which one is correct. Thanks.
THRIVE JPI MYBL FIRST TRANSNATIONAL CALL (JTC 2015) Progress Dialogue Form The aim of the Progress Dialogue is on the one hand to support the projects regarding outreach and stakeholder involvement, and
More informationNATIONAL SOCIAL REPORT Estonia
NATIONAL SOCIAL REPORT 2014 Estonia Table of contents Introduction... 3 A decisive impact on the eradication of poverty and social exclusion... 3 Recent reforms in social inclusion policies... 4 People
More informationResponses and conclusions by the FSA
FSA s Response to the Public Consultation Process on the English-Language Disclosure System Responses and conclusions by the FSA Terminology and Abbreviations Act Financial Instruments and Exchange Act
More informationNote of the meeting. Steering Group on Health Promotion, Disease Prevention and Management of Non-Communicable Diseases. Tuesday 6 November 2018
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Public health, country knowledge, crisis management Note of the meeting Steering Group on Health Promotion, Disease Prevention and Management
More informationFactsheet N 6 Project implementation: delivering project outputs, achieving project objectives and bringing about the desired change
Project implementation: delivering project outputs, achieving project objectives and bringing about the desired change Version No 13 of 23 November 2018 Table of contents I. GETTING STARTED: THE INITIATION
More informationMETHODOLOGY NOTES. TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO)
METHODOLOGY NOTES TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO) Country of Disclosure: Austria Year of Disclosure: 2018 for 2017
More information, OFFICIAL. The World Bank Office, INTERNATIONAL BANK FOR RECONSTRUCTION AND DEVELOPMENT INTERNATIONAL DEVELOPMENT ASSOCIATION.
Public Disclosure Authorized The World Bank Office, INTERNATIONAL BANK FOR RECONSTRUCTION AND DEVELOPMENT INTERNATIONAL DEVELOPMENT ASSOCIATION, OFFICIAL 28 March, 2014 Public Disclosure Authorized Public
More informationDG Justice & Consumers. Project Management.General Principles
DG Justice & Consumers Project Management.General Principles Project Life-Cycle Start Eligibility Monitoring End Eligibility Closing of Project A M E N D M E N T S Proposal Grant Agreement Progress report
More informationNational Centre for Pharmacoeconomics. Guidelines for Inclusion of Drug Costs in Pharmacoeconomic Evaluations
National Centre for Pharmacoeconomics Guidelines for Inclusion of Drug Costs in Pharmacoeconomic Evaluations Version 1.13 Please Note: This document may be updated periodically, therefore please refer
More informationSources of Health Insurance Coverage in California
Sources of Health Insurance Coverage in California Source: California HealthCare Foundation. SNAPSHOT California s Individual and Small Group Markets on the Eve of Reform, 2011. 1 Vision and Mission The
More informationEuropean Joint Programme in Radioactive Waste Management
Euratom Treaty, 1957 European Joint Programme in Radioactive Waste Management JOPRAD programme document workshop, London, 04 April 2017 DG Research and Innovation Unit G4 Fission Energy Christophe Davies
More informationPICPA DUBAI VAT WORKSHOP Dusit Thani Dubai 10 th November 2017
PICPA DUBAI VAT WORKSHOP Dusit Thani Dubai 10 th November 2017 AGENDA 1 Online Platform 2 VAT Registration 3 VAT Return 4 Case Study VAT Return Filing 2 ONLINE PORTAL 3 CREATING A PROFILE ON THE FTA WEBSITE
More informationTEMPUS Modernising Higher Education. Tempus Monitoring Policy
TEMPUS Modernising Higher Education Tempus Monitoring Policy By Jacques Kemp & Aziza Abdurakhmanova Tempus project representatives meeting Brussels, 26-27 November 2012 1 WHY Monitoring Management instrument
More informationH2020 proposal preparation RI-Links2UA Horizon 2020 Info Day 8 June, 2018
H2020 proposal preparation RI-Links2UA Horizon 2020 Info Day 8 June, 2018 Acknowledgement Slides, prepared by Gorazd Weiss are used in this presentation Today s topics 1. INTRODUCTION FROM IDEA TO IMPLEMENTATION
More informationCall for Proposals Practicalities: contractual and financial issues and application
Call for Proposals 2007 Practicalities: contractual and financial issues and application National Information Day Ministry of Health Republic of Bulgaria Sofia, 28 March 2007 Who can submit? - Participating
More informationURBACT III Programme Manual
URBACT III Programme Manual Fact Sheet 4B National URBACT Points Section 1. National URBACT Points in the URBACT III Operational programme: context and objective Section 2. Role of National URBACT Points
More informationMethodological Note to HCP/HCO Disclosure Requirements in the LEO Group including specifications from LEO Pharma A/S Romania Repressentative Office
Methodological Note to HCP/HCO Disclosure Requirements in the LEO Group including specifications from LEO Pharma A/S Romania Repressentative Office ALL LEO TRADEMARKS MENTIONED BELONG TO THE LEO GROUP
More informationThe Customs Declaration Service: a progress update
A picture of the National Audit Office logo Report by the Comptroller and Auditor General HM Revenue & Customs The Customs Declaration Service: a progress update HC 1124 SESSION 2017 2019 28 JUNE 2018
More informationAny healthcare professional and healthcare organization whose primary practice, principal professional address or place of incorporation
METHODOLOGICAL NOTE on the EFPIA disclosure of transfers of value to healthcare professionals and organizations Country: Russia Last Update: 25.04.2018 Version: 02; this document replaces previous drafts
More informationEGHI s ad hoc groups: which way forward New scenario on health information based on HIREP-ERIC progress and INFACT Joint Action launch
Ministero della Salute EGHI s ad hoc groups: which way forward New scenario on health information based on HIREP-ERIC progress and INFACT Joint Action launch Giovanni Nicoletti Luxembourg, December 6.,
More informationDISCLOSURE OF TRANSFERS OF VALUE TO HEALTHCARE PROFESSIONALS AND HEALTHCARE ORGANISATIONS
DISCLOSURE OF TRANSFERS OF VALUE TO HEALTHCARE PROFESSIONALS AND HEALTHCARE ORGANISATIONS METHODOLOGICAL NOTES Date of Issue: June 2017 Country Scope: Ireland Version: 1.0 CONTENTS INTRODUCTION... 4 CONTENT...
More informationRecommendations for improving the medicinal product pricing process
Recommendations for improving the medicinal product pricing process Zagreb, June 2018 Contents Introduction... 3 The Current Situation in the Republic of Croatia... 4 Time Frames for Issuing Decisions...
More informationPAC Guidelines for Project Progress Report
PAC Guidelines for Project Progress Report Version 1.0 September 2017 A stream of cooperation Programme co-funded by the European Union Content List of abbreviations... 5 Introduction... 6 PART I TECHNICAL
More informationDemographic Change in the EU, the Oldest-old and the Need for Innovative Models of More Efficient Elderly Care
Demographic Change in the EU, the Oldest-old and the Need for Innovative Models of More Efficient Elderly Care Martin Karlsson, CINCH University of Duisburg-Essen March 7, 2017 Martin Karlsson Demographic
More informationProject Selection Criteria Transnational Cooperation Programme Interreg Balkan Mediterranean
Project Selection Criteria Transnational Cooperation Programme Interreg Balkan Mediterranean 2014 2020 CCI 2014TC16M4TN003 22/06/2015 Version 1.0 Balkan-Mediterranean is co-financed by European Union and
More informationGlobal Transfer Pricing Review
GLOBAL TRANSFER PRICING SERVICES Global Transfer Pricing Review Austria kpmg.com/gtps TAX 2 Global Transfer Pricing Review Austria KPMG observation On 28 October 2010, the Austrian Federal Ministry of
More informationProject Title: INFRASTRUCTURE AND INTEGRATED TOOLS FOR PERSONALIZED LEARNING OF READING SKILL
Project Title: INFRASTRUCTURE AND INTEGRATED TOOLS FOR PERSONALIZED LEARNING OF READING SKILL Project Acronym: Grant Agreement number: 731724 iread H2020-ICT-2016-2017/H2020-ICT-2016-1 Subject: Dissemination
More informationDISCLOSURE OF TRANSFERS OF VALUE TO HEALTHCARE PROFESSIONALS AND HEALTHCARE ORGANISATIONS
DISCLOSURE OF TRANSFERS OF VALUE TO HEALTHCARE PROFESSIONALS AND HEALTHCARE ORGANISATIONS METHODOLOGICAL NOTES Date of Issue: June 2016 Country Scope: Hungary & Sweden Version: 1.0 Name Title Written:
More informationTERMS OF REFERENCE FOR CONDUCTING MID-TERM EVALUATION FOR MALARIA PROJECT IN GEITA
TERMS OF REFERENCE FOR CONDUCTING MID-TERM EVALUATION FOR MALARIA PROJECT IN GEITA Harnessing on the Private Health Sectors Potential in the Fight against Malaria 1.0. Introduction and Background Information
More informationECB-PUBLIC DECISION (EU) 2017/[XX*]OF THE EUROPEAN CENTRAL BANK. of 27 June 2017
EN ECB-PUBLIC DECISION (EU) 2017/[XX*]OF THE EUROPEAN CENTRAL BANK of 27 June 2017 on the reporting of funding plans of credit institutions by national competent authorities to the European Central Bank
More informationNew Challenging ESPON Projects for more than 7 million Euro
, 25 August 2011 Welcome to the ESPON Newsletter. It offers information on the latest developments of the ESPON Programme. Message from the ESPON Coordination Unit New Challenging ESPON Projects for more
More informationInterim Activity Report
EUROPEAN COMMISSION Executive Agency for Small and Medium-sized Enterprises (EASME) Department A - COSME, H2020 SME and EMFF Unit A3 - EMFF Call reference No: CALL MARE/2014/46 Project Full Name: Action
More informationANNEX A - I. Note: it is important that each tenderer has read the Working Practice and its annexes very carefully.
ANNEX A - I Note: it is important that each tenderer has read the Working Practice and its annexes very carefully. WORKING PRACTICE 1.GENERAL INFORMATION 1.1.THE AUDIT CO-ORDINATOR 1.1.1.The Audit Co-ordinator
More informationERA-NET COFUND Financial Aspects General Principles. An overview and practical examples October 2016
ERA-NET COFUND Financial Aspects General Principles An overview and practical examples October 2016 1 Content general financial aspects ERA-NET Cofund eligible costs and EC contribution calculation of
More information